Navigation Links
OTC Industry Announces Voluntary Transition to One Concentration of Single-Ingredient Pediatric Liquid Acetaminophen Medicines
Date:5/5/2011

WASHINGTON, May 5, 2011 /PRNewswire-USNewswire/ -- Today, the Consumer Healthcare Products Association (CHPA), representing the makers of over-the-counter (OTC) single-ingredient liquid pediatric acetaminophen medicines, announces plans to convert these pediatric products to just one concentration. While the transition is taking place, starting in mid-2011, parents and caregivers can continue to use their current products with confidence as current labeling and dosing instructions for these children's medicines are accurate for safe and appropriate use.  

Presently, families can purchase more than one concentration of single-ingredient pediatric liquid acetaminophen medicines in the United States. This voluntary change means the current children's strength of liquid acetaminophen (160 mg / 5 mL) will become the only liquid concentration available for all children under 12-years-old, and the current concentrated infant drops will no longer be sold.

"CHPA member companies are voluntarily making this conversion to one concentration to help make it easier for parents and caregivers to appropriately use single-ingredient liquid acetaminophen," said CHPA President and CEO Scott Melville. "We are committed to providing parents and caregivers with the tools and information they need to help give their children the right amount of these medicines."

CHPA and its members will be working to ensure healthcare providers have the information they need to help answer parents' questions about the change. During the transition, the makers of these medicines also will work with retailers to ensure that, as the new medicines are introduced, the more concentrated infant drops will be removed from store shelves.

It is important to be aware that there will be a time period when both concentrations of infants' acetaminophen liquid products (the concentrated drops and the new 160 mg / 5 mL concentration) will be available in stores and in medicine cabinets. Consumers should always read and follow the label and pay particular attention to the concentration, especially when a healthcare provider gives dosing instructions.

The single-concentration liquid medicines will have additional enhancements to their age-appropriate dosing devices. Specifically, infants' products will have syringes for more accurate dosing and flow restrictors. Children's products, for ages two to under 12-years-old, will continue to offer dosing cups.

Acetaminophen is the most commonly used children's medicine for relieving pain and reducing fever. It provides parents and caregivers with an important doctor-recommended treatment option for relieving pain and fever in children when used as labeled.

More information is available at www.chpa-info.org.

CHPA is the 130-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.

chpa-info.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance
2. Reportlinker Adds Pharmaceutical Key Trends 2011 - Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
3. Top Three Healthcare Supply Chain Executives Challenge Industry
4. Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations
5. Awarepoint to Showcase Industry-leading Real-time Location System (RTLS) at AONE Annual Meeting
6. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
7. Reportlinker Adds Global: Pharmaceuticals Industry Guide
8. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
9. FDA to Address Industry Questions About Biosimilar Regulations at the Pharmas IQ Immunogenicity Event
10. Reportlinker Adds Top 500 Pharmaceuticals Industry Report (Global)
11. Reportlinker Adds Top 200 Biopharmaceuticals Industry Report (Global)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... DIEGO , Feb. 10, 2016 ALSP, Inc. ... , MD as Consultant for Medical Affairs in preparation for ... Michael Pierschbacher , PhD, CEO, stated, "We are pleased ... We look forward to working with an individual of such ... We look forward to drawing deeply on his broad experience ...
(Date:2/10/2016)... , Feb. 10, 2016 Intouch Solutions, a ... identified an industry-wide trend regarding the evolution of ... organizations to efficiently deliver compelling sales presentations via ... and another in 2015, Intouch uncovered that while ... devices and DSAs, many are not using them ...
(Date:2/10/2016)... HALLANDALE, Fla. , Feb. 9, 2016  Until ... sagging were surgery or liposuction. Thankfully, the FDA approved ... freezing them to death. Coolsculpting was originally approved in ... to the thighs and now the chin. With this ... Wellness Center can use a smaller applicator, the CoolMini, ...
Breaking Medicine Technology:
(Date:2/10/2016)... Calif. (PRWEB) , ... February 10, 2016 , ... ... Water Brand. There were three leading bottled water brand owners that topped the list ... that enhance connectivity and optimize conversion. The premier brand was Tibet 5100, a top ...
(Date:2/10/2016)... ... ... Dr. Jessica Barron, of Barron Family Dental in Thornton, Colorado , ... in the North Metro Denver area. The new dental practice focuses on comfort where ... in the most relaxing environment. , While some dental visits can create anxiety for ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s ... together more than 200 of the country’s top healthcare executives to share insights ... true benefit of the Forum is the provider-centric perspective, experience, expertise and strategy ...
(Date:2/10/2016)... ... February 10, 2016 , ... Gout is like no other joint ... is often severe, with intense swelling and redness. It is triggered by the crystallization ... older adults are the most susceptible, according to the February 2016 issue of Harvard ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Armune ... Apifiny® across their network of laboratory service centers across the country. Launched in ... aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests ...
Breaking Medicine News(10 mins):